Trending:
News
-
17 August 2018
EpiPen generic version by Teva secures FDA approval
The US Food and Drug Administration (FDA) has approved the first generic version of the EpiPen to treat allergic reactions in emergency cases, including life-threatening (anaphylaxis) conditions.
-
17 August 2018
NHS adopts HeartFlow’s AI technology to tackle coronary heart disease
The UK's National Health Service (NHS) has adopted HeartFlow’s artificial intelligence (AI) technology across its network of hospitals to address coronary heart disease.
-
17 August 2018
AngioDynamics acquires BioSentry system from Surgical Specialties
Vascular access solutions developer AngioDynamics has acquired the BioSentry Tract Sealant System from medical devices firm Surgical Specialties for an undisclosed amount.
-
17 August 2018
Deals and M&As this week: Siemens, Boston Scientific
German healthcare firm Siemens has formed a strategic collaboration with NuVasive to develop novel technologies for spine surgery procedures.
-
16 August 2018
Nu-Med optimistic about nitric oxide prospects after patent ruling
Nu-Med Plus, the medical nitric oxide delivery developer, is anticipating a favourable market environment for its products after recent patent rulings.
-
16 August 2018
Wearable device can measure electrophysiological signals
A research team at the Center for Nanoparticle Research, within the Institute for Basic Science (IBS), has developed a wearable and implantable device that measures electrophysiological signals and applies electrical...
-
16 August 2018
Medtronic launches IN.PACT Admiral Drug-Coated Balloon in Japan
Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan.
-
16 August 2018
Self-fitting scaffold improves bone injury recovery
Researchers from the Hong Kong Polytechnic University (PolyU) have created a self-fitting scaffold that can be implanted into bone defects to stimulate bone regeneration.
-
15 August 2018
New genome analysis scores risk of serious common diseases
A research team in the US has devised a new genome analysis approach that can identify large proportions of people who are at a higher risk of developing serious common...
-
15 August 2018
VolitionRx reports positive data for prostate cancer assay
Cancer diagnostics developer VolitionRx has reported positive preliminary results from a proof of concept clinical study of its Nu.Q assays to detect high-grade prostate cancer.
